Biomarin Pharmaceutical shares owned by Loomis, Sayles and
Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by Loomis, Sayles and
from 13F filings
Historical chart of Loomis, Sayles and investment in Biomarin Pharmaceutical
Tip: Access up to 7 years of quarterly data
All positions including Biomarin Pharmaceutical held by Loomis, Sayles and consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Biomarin Pharmaceutical by Loomis, Sayles and
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $182M | 2.1M | 87.34 |
| 2023-09-30 | $184M | 2.1M | 88.48 |
| 2023-06-30 | $178M | 2.1M | 86.68 |
| 2023-03-31 | $200M | 2.1M | 97.24 |
| 2022-12-31 | $216M | 2.1M | 103.49 |
| 2022-09-30 | $186M | 2.2M | 84.77 |
| 2022-06-30 | $189M | 2.3M | 82.87 |
| 2022-03-31 | $176M | 2.3M | 77.10 |
| 2021-12-31 | $204M | 2.3M | 88.35 |
| 2021-09-30 | $188M | 2.4M | 77.29 |
| 2021-06-30 | $198M | 2.4M | 83.44 |